Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science.
'Owing to the strong potential as antivirals exhibited to date by PCIs, cellular proteins are now starting to be considered more often as valid targets for antiviral drugs'
Schang
Luis M
LM
D000998:Antiviral Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D004261:DNA Replication / Q000187:drug effects*; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D018844:Cyclin-Dependent Kinases